ESR1 and cancer: Moreover, in SUM-44 hormone receptor-postive breat cancer cells, overexpression of NSD3S drives estrogen receptor alpha (ERα) activity in an estrogen-independent manner, and its depletion leads to reduced ER expression and impaired cell proliferation [160], highlighting the critical role of NSD3S in breat cancer pathogenesis.